Our mission is to explore important research questions about the microbiome and to develop accurate and reliable clinical tests based on the microbiome.
uBiome was launched in 2012 by scientists and technologists educated at Stanford, UCSF, and Oxford after a crowdfunding campaign raised more than $350,000 from citizen scientists, roughly triple its initial goal. The company is now funded by Y Combinator, Andreessen Horowitz, and other investors.
Nature Biotechnology - January 10, 2017
Gut microbiome profiling tests propelled by customer demand
"San Francisco–based uBiome in November launched SmartGut, a clinical microbiome screening test that measures bacterial diversity in a person’s gut using DNA sequencing."
Fortune - November 2, 2016
Why Gut Bacteria Are Having a Moment
"Research has started to show that the microbiome is linked to mental health issues, such as depression and anxiety."
ELLE Magazine - October 27, 2016
The Ultimate Guide to DIY DNA Testing Kits
"I think health care will be controlled by the patients. We're the ones who care most about our health."
Medscape - June 21, 2016
Citizen Science and Mapping the Microbiome
“How we can involve the public in science at a broader level. We have 7 million scientists now. What would our world look like if we had 20 million, or 100 million, or 1 billion?”
New York Magazine - May 30, 2016
Everything You Need to Know About Poop
"We could see [the citizen scientist's] microbiome change pretty dramatically to fat-digesting bacteria versus carbohydrate-digesting bacteria within three days."
February 10, 2017 – uBiome Announces SmartBiome ID™: Sample-Agnostic Pathogen Detection Platform
November 1, 2016 – uBiome Announces World’s First Sequencing-Based Clinical Microbiome Test